Terms ending in 2042
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,865,177 | Composition and Methods for Stabilizing Liquid Protein Formulations In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,834,709 | Multiplexed Target-Binding Candidate Screening Analysis In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,932,675 | PD-1 Targeted IL-15/IL-15RALPHA FC Fusion Proteins with Improved Properties In force · High confidence | Xencor, Inc. | In force | High confidence | |
| US 12,486,315 | Developing an Efficient Hybridoma Platform for Therapeutic Antibody Discovery In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,152,040 | Tert-Butyl (S)-2-(4-(PHENYL)-6H-THIENO[3, 2-F][1, 2, 4]TRIAZOLO[4, 3-A] [1,4]DIAZEPIN-6-YL) Acetate Derivatives and Related Compounds as Bromodomain BRD4 Inhibitors for Treating Cancer In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,205,386 | Cell Line Development Image Characterization with Convolutional Neural Networks In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,381,013 | Predicting Tolerability in Aggressive Non-Hodgkin Lymphoma In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 12,171,805 | IL-22 Fc PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,881,286 | CD8+ T Cell Based Immunosuppressive Tumor Microenvironment Detection Method In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 12,286,619 | Modulating Lactogenic Activity in Mammalian Cells In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| 51 more term ends in 2042 · Pro | |||||
10 of 61 patents shown. Soonest term end first, then patent number.
Pro members see all 61.
54 of these are in force and held by Genentech, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.